Androgen Receptor Mediates Non-genomic Activation of Phosphatidylinositol 3-OH Kinase in Androgen-sensitive Epithelial Cells

Silvère Baron, M. Manin, Claude Beaudoin, Laurent Léotoing, Yves Communal, G. Veyssière, Laurent Morel

Journal of Biological Chemistry · 2004 · 173 citations · 34 references

DOIFull text

Open access

Concepts

Abstract

Androgens are known to modulate many cellular processes such as cell growth and survival by binding to the androgen receptor (AR) and activating the transcription of target genes. Recent data suggested that AR can also mediate non-transcriptional actions outside the nucleus in addition to its ligand-inducible transcription factor function. Here, we describe a transcription-independent activation of the phosphatidylinositol 3-OH kinase (PI3-K) signaling pathway by androgens. Using non-transformed androgen-sensitive epithelial cells, we show that androgens enhance the PI3-K activity by promoting accumulation of phosphoinositide-3-P phospholipids in vitro. This activation is found in conjunction with an increased time-dependent phosphorylation of the downstream kinase AKT/protein kinase B on both Ser473 and Thr308 residues. Hormone-stimulated phosphorylation of AKT requires AR since incubation with the anti-androgen bicalutamide completely abolishes the androgen-stimulated AKT phosphorylation. Accordingly, we show that androgens increase AKT phosphorylation level in prostatic carcinoma PC3 cells only once they have been transfected with AR. Downstream, androgens enhance phosphorylation of transcription factor FKHR (Forkhead in rhabdomyosarcoma)-L1 and proapoptotic Bad protein and promote cell survival as they can counteract an apoptotic process. We also report that non-genomic effects of androgens are based on direct interaction between AR and the p85α regulatory subunit of class I(A) PI3-K. Together, these novel findings point out an important and physiologically relevant link between androgens and the PI3-K/AKT signaling pathway in governing cell survival. Androgens are known to modulate many cellular processes such as cell growth and survival by binding to the androgen receptor (AR) and activating the transcription of target genes. Recent data suggested that AR can also mediate non-transcriptional actions outside the nucleus in addition to its ligand-inducible transcription factor function. Here, we describe a transcription-independent activation of the phosphatidylinositol 3-OH kinase (PI3-K) signaling pathway by androgens. Using non-transformed androgen-sensitive epithelial cells, we show that androgens enhance the PI3-K activity by promoting accumulation of phosphoinositide-3-P phospholipids in vitro. This activation is found in conjunction with an increased time-dependent phosphorylation of the downstream kinase AKT/protein kinase B on both Ser473 and Thr308 residues. Hormone-stimulated phosphorylation of AKT requires AR since incubation with the anti-androgen bicalutamide completely abolishes the androgen-stimulated AKT phosphorylation. Accordingly, we show that androgens increase AKT phosphorylation level in prostatic carcinoma PC3 cells only once they have been transfected with AR. Downstream, androgens enhance phosphorylation of transcription factor FKHR (Forkhead in rhabdomyosarcoma)-L1 and proapoptotic Bad protein and promote cell survival as they can counteract an apoptotic process. We also report that non-genomic effects of androgens are based on direct interaction between AR and the p85α regulatory subunit of class I(A) PI3-K. Together, these novel findings point out an important and physiologically relevant link between androgens and the PI3-K/AKT signaling pathway in governing cell survival. Steroid hormones exert most of their effects by binding to specific nuclear receptors, which act as transcription factors (1Evans R.M. Science. 1988; 240: 889-895Crossref PubMed Scopus (6341) Google Scholar, 2Giguere V. Yang N. Segui P. Evans R.M. Nature. 1988; 331: 91-94Crossref PubMed Scopus (700) Google Scholar, 3Mangelsdorf D.J. Thummel C. Beato M. Herrlich P. Schutz G. Umesono K. Blumberg B. Kastner P. Mark M. Chambon P. et al.Cell. 1995; 83: 835-839Abstract Full Text PDF PubMed Scopus (6110) Google Scholar). The relationship between steroid target genes and steroid physiological actions suggest that mechanisms, different from those controlling the transcriptional activity of nuclear receptors, may be involved. In recent years, steroids have been found to control the activity of multiple signaling pathways via non-genomic mechanisms (for a review, see Ref. 4Falkenstein E. Tillmann H.C. Christ M. Feuring M. Wehling M. Pharmacol. Rev. 2000; 52: 513-556PubMed Google Scholar). Nongenomic activities of estrogen receptor (ER) 1The abbreviations used are: ER, estrogen receptor; AR, androgen receptor(s); PR, progesterone receptor; PI3-K, phosphatidylinositol 3-OH kinase; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; ANOVA, analysis of variance; PARP, poly-ADP ribosyl polymerase; VDEC, vas deferens epithelial cells; PMSF, phenylmethylsulfonyl fluoride; PBS, phosphate-buffered saline; GST, glutathione S-transferase; CHX, cycloheximide; IGF-I, insulin-like growth factor-I; PtdIns, phosphoinositides; P, phosphorylated; h, human; FKHR, Forkhead in rhabdomyosarcoma. were the first described and associated to vascular protection through nitric oxide production in endothelial cells, involving the phosphatidylinositol 3-OH kinase (PI3-K) and subsequent endothelial nitric-oxide synthase activation (5Chen Z. Yuhanna I.S. Galcheva-Gargova Z. Karas R.H. Mendelsohn M.E. Shaul P.W. J. Clin. Invest. 1999; 103: 401-406Crossref PubMed Scopus (796) Google Scholar, 6Simoncini T. Hafezi-Moghadam A. Brazil D.P. Ley K. Chin W.W. Liao J.K. Nature. 2000; 407: 538-541Crossref PubMed Scopus (1234) Google Scholar, 7Chambliss K.L. Yuhanna I.S. Mineo C. Liu P. German Z. Sherman T.S. Mendelsohn M.E. Anderson R.G. Shaul P.W. Circ. Res. 2000; 87: E44-E52Crossref PubMed Google Scholar, 8Hisamoto K. Ohmichi M. Kurachi H. Hayakawa J. Kanda Y. Nishio Y. Adachi K. Tasaka K. Miyoshi E. Fujiwara N. Taniguchi N. Murata Y. J. Biol. Chem. 2001; 276: 3459-3467Abstract Full Text Full Text PDF PubMed Scopus (328) Google Scholar). Estrogens and both ERα and ERβ rapid effects have been studied in a wide range of physiological or pathological conditions and cell types, including neurons (9Moss R.L. Gu Q. Steroids. 1999; 64: 14-21Crossref PubMed Scopus (84) Google Scholar), endothelial cells, osteoblasts, and breast cancer cells (10Sun M. Paciga J.E. Feldman R.I. Yuan Z. Coppola D. Lu Y.Y. Shelley S.A. Nicosia S.V. Cheng J.Q. Cancer Res. 2001; 61: 5985-5991PubMed Google Scholar). Some other steroid receptors such as progesterone receptor (PR) (11Migliaccio A. Piccolo D. Castoria G. Di Domenico M. Bilancio A. Lombardi M. Gong W. Beato M. Auricchio F. EMBO J. 1998; 17: 2008-2018Crossref PubMed Scopus (523) Google Scholar, 12Bayaa M. Booth R.A. Sheng Y. Liu X.J. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 12607-12612Crossref PubMed Scopus (188) Google Scholar, 13Bagowski C.P. Myers J.W. Ferrell Jr., J.E. J. Biol. Chem. 2001; 276: 37708-37714Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 14Boonyaratanakornkit V. Scott M.P. Ribon V. Sherman L. Anderson S.M. Maller J.L. Miller W.T. Edwards D.P. Mol. Cell. 2001; 8: 269-280Abstract Full Text Full Text PDF PubMed Scopus (502) Google Scholar) but also androgen receptor (AR) (15Peterziel H. Mink S. Schonert A. Becker M. Klocker H. Cato A.C. Oncogene. 1999; 18: 6322-6329Crossref PubMed Scopus (220) Google Scholar, 16Migliaccio A. Castoria G. Di Domenico M. de Falco A. Bilancio A. Lombardi M. Barone M.V. Ametrano D. Zannini M.S. Abbondanza C. Auricchio F. EMBO J. 2000; 19: 5406-5417Crossref PubMed Google Scholar, 17Kousteni S. Bellido T. Plotkin L.I. O'Brien C.A. Bodenner D.L. Han L. Han K. DiGregorio G.B. Katzenellenbogen J.A. Katzenellenbogen B.S. Roberson P.K. Weinstein R.S. Jilka R.L. Manolagas S.C. Cell. 2001; 104: 719-730Abstract Full Text Full Text PDF PubMed Google Scholar) have been recently highlighted to mediate non-genomic activities. Kousteni et al. (17Kousteni S. Bellido T. Plotkin L.I. O'Brien C.A. Bodenner D.L. Han L. Han K. DiGregorio G.B. Katzenellenbogen J.A. Katzenellenbogen B.S. Roberson P.K. Weinstein R.S. Jilka R.L. Manolagas S.C. Cell. 2001; 104: 719-730Abstract Full Text Full Text PDF PubMed Google Scholar) demonstrated that ERα, ERβ, and AR, associated in the same complex, can protect osteoblasts and osteocytes from apoptosis through the Src/Shc/ERK signaling pathway. Moreover, such association of either AR with ERβ in LNCaP cells or AR with ERα in MCF-7 and T47-D cell lines was described to trigger cell proliferation through the same pathway (16Migliaccio A. Castoria G. Di Domenico M. de Falco A. Bilancio A. Lombardi M. Barone M.V. Ametrano D. Zannini M.S. Abbondanza C. Auricchio F. EMBO J. 2000; 19: 5406-5417Crossref PubMed Google Scholar). In PC3 cells stably expressing AR, androgens are able to increase the enzymatic activities of several cytoplasmic kinases such as the mitogen-activated protein kinases (MAPKs), the protein kinase C, and the PI3-K (15Peterziel H. Mink S. Schonert A. Becker M. Klocker H. Cato A.C. Oncogene. 1999; 18: 6322-6329Crossref PubMed Scopus (220) Google Scholar). Although non-genomic steroid receptor activities mediated by the PI3-K pathway are now well documented for ER and PR, they remain poorly investigated concerning AR. Three classes of PI3-K have been described depending on their primary structure and substrate specificity (18MacDougall L.K. Domin J. Waterfield M.D. Curr. Biol. 1995; 5: 1404-1415Abstract Full Text Full Text PDF PubMed Scopus (128) Google Scholar, 19Surdo P.L. Bottomley M.J. Arcaro A. Siegal G. Panayotou G. Sankar A. Gaffney P.R. Riley A.M. Potter B.V. Waterfield M.D. Driscoll P.C. J. Biol. Chem. 1999; 274: 15678-15685Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar). Class I(A) comprises five adapter subunits currently known. Of these, three are encoded by the p85α gene, generating p85α, p55α, and p50α by alternative splicing. These regulatory subunits regulate catalytic subunits p110α, -β, and -δ, which enhance phosphorylation of phosphoinositides (PtdIns-P) in D3 position of the inositol ring (20Fruman D.A. Meyers R.E. Cantley L.C. Annu. Rev. Biochem. 1998; 67: 481-507Crossref PubMed Scopus (1323) Google Scholar). The class I(A) p85α/p110α heterodimer, the most studied PI3-K, supports a large number of insulin and growth factor cellular effects (21Ruderman N.B. Kapeller R. White M.F. Cantley L.C. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 1411-1415Crossref PubMed Scopus (397) Google Scholar, 22Escobedo J.A. Navankasattusas S. Kavanaugh W.M. Milfay D. Fried V.A. Williams L.T. Cell. 1991; 65: 75-82Abstract Full Text PDF PubMed Scopus (375) Google Scholar, 23Cantley L.C. Science. 2002; 296: 1655-1657Crossref PubMed Scopus (4681) Google Scholar, 24Ueki K. Yballe C.M. Brachmann S.M. Vicent D. Watt J.M. Kahn C.R. Cantley L.C. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 419-424Crossref PubMed Scopus (199) Google Scholar). In vivo, the main phosphorylated lipids generated by PI3-K class I(A) are the PtdIns-3,4-P3 and PtdIns-3,4,5-P3, which in turn recruit signaling kinases such as the AKT/protein kinase B (25Franke T.F. Kaplan D.R. Cantley L.C. Cell. 1997; 88: 435-437Abstract Full Text Full Text PDF PubMed Scopus (1528) Google Scholar). Activation of AKT by phosphorylation of the Ser473 and Thr308 residues (26Alessi D.R. James S.R. Downes C.P. Holmes A.B. Gaffney P.R. Reese C.B. Cohen P. Curr. Biol. 1997; 7: 261-269Abstract Full Text Full Text PDF PubMed Google Scholar) mediates many of the downstream PI3-K effects, including protection against apoptosis. This control involves the phosphorylation of many proteins, including the transcription factor of the Forkhead family (FKHR) (27Brunet A. Bonni A. Zigmond M.J. Lin M.Z. Juo P. Hu L.S. Anderson M.J. Arden K.C. Blenis J. Greenberg M.E. Cell. 1999; 96: 857-868Abstract Full Text Full Text PDF PubMed Scopus (5454) Google Scholar) and the pro-apoptotic factor Bad (28Zha J. Harada H. Yang E. Jockel J. Korsmeyer S.J. Cell. 1996; 87: 619-628Abstract Full Text Full Text PDF PubMed Scopus (2257) Google Scholar, 29Gajewski T.F. Thompson C.B. Cell. 1996; 87: 589-592Abstract Full Text Full Text PDF PubMed Scopus (299) Google Scholar). In this study, we report that androgens can activate PI3-K in androgen-sensitive epithelial cells. The PI3-K activation results in the phosphorylation of the downstream AKT/protein kinase B, FKHR-L1, and Bad protein and is supported by direct interactions between AR and p85α, involving the N-terminal SH3 and C-terminal SH2 domains of the regulatory subunit. Finally, we demonstrate that androgenic activation of the PI3-K/AKT pathway by AR acts as a anti-apoptotic stimulus in epithelial cells. Reagents—R1881, insulin-like growth factor-I (IGF-I), and Wortmannin were obtained from Sigma. LY294002 was purchased from Biomol, and Bicalutamide (Casodex®) was purchased from Astra-Zeneca. Antibodies against PI3-K subunit p85α (catalog number 06-195) and AR (catalog number PG21) were from Upstate Biotechnology; AKT (catalog number 9272), phospho-AKT Ser473 (catalog number 9271), phospho-AKT Thr308 (catalog number 9275), phospho-Bad Ser112 (catalog number 9296), and phospho-FKHR-L1 Ser256 (catalog number 9461) were from Cell Signaling; poly-ADP ribosyl polymerase (PARP) (catalog number C2-10) was from Trevigen Inc.; and β-actin (catalog number A2066) was from Sigma. Cell Culture and Transfections—Mouse vas deferens epithelial cells (VDEC) were cultured as already described (30Manin M. Baron S. Goossens K. Beaudoin C. Jean C. Veyssiere G. Verhoeven G. Morel L. Biochem. J. 2002; 366: 729-736Crossref PubMed Google Scholar). Cells were starved for 16 h in Dulbecco's modified Eagle's and with or or LY294002 or Wortmannin were and were through the PC3 cells were in modified Eagle's and Cells were transfected the and and were by C. and B. The p85α was the and of by the p85α from the and the downstream The and domains of p85α were obtained by and the were the with the of the The were by the and its and binding domains the or the or generated by the PI3-K were starved 16 h in the addition of hormones the cells were in PMSF, and for Cell were to and protein for h were with with B and with were in and phosphorylation were in the of of and of for The were by the addition of and the phospholipids were with were and in and by The phosphorylated lipids were by and a were in and in PMSF, were in and to were to by in and with the primary in the same The were three with and h with either or was of with were in was in to a of and for h Cells were in were in and were for and for The was with and were three with and AR and p85α were generated in the were with the in binding of PMSF, and by h The were in and in from by for and to were with by and a were with and in Cell were and of protein was to and protein five with and the were in and by as described the was with for and were with for in the Cells were for the of and apoptotic a cells were and in were in an and h in the Cell were a cell The of apoptotic cells was by were for were by a analysis of by of were and are Androgens the PI3-K/AKT in of androgens to enhance the PI3-K activity in that AR was The PI3-K p85α regulatory subunit was and the phosphorylation of the PI3-K was by of with was associated with a increase in the production in This kinase activity is on the PI3-K as was by an of the catalytic subunit of the PI3-K H. M. Cohen P. Biochem. J. 2000; PubMed Scopus Google Scholar). The activation of the kinase activity in to this androgenic was to be to in the of p85α and AR as they the PI3-K the of on the and to the of the these is the kinase which mediates a large range of the PI3-K cellular androgens can activate we its phosphorylation on the Ser473 known to be in a by growth incubation with in a to that obtained AKT activation is on the phosphorylation of specific Ser473 in the regulatory but also Thr308 in the kinase We the of androgens to the phosphorylation of in addition to that of In the of Thr308 phosphorylation was and the level The phosphorylation on the Ser473 in to androgens was and and phosphorylation is and for PI3-K is or for AKT phosphorylation in to the Ser473 phosphorylation was in the of of a PI3-K H. M. Cohen P. Biochem. J. 2000; PubMed Scopus Google Scholar). of with LY294002 and AKT with an as as we have demonstrated that AR level is on the PI3-K/AKT pathway and that LY294002 AR (30Manin M. Baron S. Goossens K. Beaudoin C. Jean C. Veyssiere G. Verhoeven G. Morel L. Biochem. J. 2002; 366: 729-736Crossref PubMed Google Scholar). in the of the PI3-K AR accumulation a was investigated downstream to such as the transcription factor or the pro-apoptotic factor be phosphorylated androgenic These are known to be by AKT through phosphorylation of Ser256 and phosphorylation was increased a and its level h of The Bad protein was and FKHR-L1, the phosphorylation level of Bad in to androgens was a between and of data suggest that different mechanisms be in the control of and Bad they are a substrate of the same These demonstrate that androgen of AKT to phosphorylation of AR for the PI3-K/AKT demonstrate AR is in the androgenic activation of the PI3-K, AKT phosphorylation on Ser473 was in the of both and a anti-androgen Bicalutamide AKT phosphorylation that AR is for activation of the PI3-K/AKT pathway. This on in AR accumulation since in the different We also AKT Ser473 phosphorylation in PC3 carcinoma cells, which AR. These cells were transfected with of either an or the in the increase in the phosphorylation level on the Ser473 was on the of the AR. In this AR was able to mediate a AKT phosphorylation in cells this was AR was by These results that androgen receptor is a for androgen on PI3-K pathway since PC3 cells of AR are to enhance AKT phosphorylation in of The Activation of the PI3-K/AKT by a between AR and demonstrated that steroid receptors, such as and estrogen receptors, with the p85α regulatory subunit of PI3-K. such interactions can between p85α and AR, we p85α in AR was in the p85α complex, and interaction is by The interaction were investigated We the binding of in to the N-terminal binding or binding of AR to the AR p85α but the binding and C-terminal interactions N-terminal We investigated the interaction of the different p85α domains to only the SH3 and domains binding The binding of androgen receptor to p85α in was of the these data demonstrate that interaction direct interaction involving SH3 and of the regulatory subunit. Androgens against apoptosis through PI3-K can the PI3-K we investigated this non-genomic be able to control cell survival. this we first the apoptotic apoptosis in a in by cells in with the of and apoptotic as by that these from an apoptotic we analysis to which is specific to the apoptotic process. accumulation of the We investigated androgen effects on apoptosis and the of apoptotic cell by by were for h with to increase AR (30Manin M. Baron S. Goossens K. Beaudoin C. Jean C. Veyssiere G. Verhoeven G. Morel L. Biochem. J. 2002; 366: 729-736Crossref PubMed Google Scholar) and with LY294002 to non-genomic of androgens and to that the with the PI3-K cell survival pathway. Cells were starved for 16 h in a that AR level but growth signaling this were for h with in the or in the of LY294002 to the addition of to the non-genomic of androgens on apoptosis. an incubation was able to cell apoptotic cell from to In LY294002 with the androgen effects in a LY294002 these results that supports an important in epithelial cell survival through the non-genomic activation of PI3-K. We show that the androgen receptor is able to activate the PI3-K/AKT pathway through direct interaction with the p85α regulatory subunit in to but also to androgens androgenic activation of the PI3-K to the phosphorylation of AKT and the Bad and androgen the to epithelial cell growth and to epithelial apoptosis in the vas and many have been to the mechanisms by which they are able to act in these Although androgens were demonstrated to act on proliferation processes through the signaling their on the PI3-K/AKT pathway investigated The PI3-K pathway is a signaling that a of extracellular and several cellular including cell and survival R. Panayotou G. S. M.J. P. K. et J. PubMed Scopus Google Scholar, S. P. F. K. K. M. T. L. L. Curr. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, R. Oncogene. 1996; Google Scholar). the in the of cell the transcription factors of the Forkhead family (27Brunet A. Bonni A. Zigmond M.J. Lin M.Z. Juo P. Hu L.S. Anderson M.J. Arden K.C. Blenis J. Greenberg M.E. Cell. 1999; 96: 857-868Abstract Full Text Full Text PDF PubMed Scopus (5454) Google Scholar) and the pro-apoptotic protein Bad (28Zha J. Harada H. Yang E. Jockel J. Korsmeyer S.J. Cell. 1996; 87: 619-628Abstract Full Text Full Text PDF PubMed Scopus (2257) Google Scholar, 29Gajewski T.F. Thompson C.B. Cell. 1996; 87: 589-592Abstract Full Text Full Text PDF PubMed Scopus (299) Google Scholar), a of the are the of the PI3-K/AKT pathway. Using androgen-sensitive epithelial cells (VDEC) M. P. A. S. Jean C. Biol. 1995; 52: PubMed Scopus Google Scholar, M. A. B. Jean C. J. 2000; Google Scholar), we demonstrate that androgens are able to the PI3-K, to the phosphorylation of AKT and its downstream Bad and such an activation of the PI3-K survival pathway is associated with a protection against apoptosis by androgens in The data to a for androgen on which is different from that and androgens are described as of epithelial cell via factors such as and growth factor 1996; PubMed Google Scholar, T. C. R. Cell 2001; 8: PubMed Scopus Google Scholar). Here, we show that androgens act on epithelial cells and trigger survival signaling by the PI3-K, the primary of the et al. P. H. S. G. W. Mol. Cell. Biol. PubMed Scopus Google Scholar) have also demonstrated a link between androgen and growth factor signaling pathways in cells in which AR can activate the FKHR transcription but in an such a is to be specific to this cell as we a rapid increase in the phosphorylation of AKT in to androgens in non-transformed epithelial cells. important of this is to the and subsequent mechanisms in the of cell processes in of non-genomic mechanisms have that steroids act through steroid receptors or through receptors J. Steroid Biochem. Mol. Biol. 1995; 52: PubMed Scopus Google Scholar). results show that the androgen receptor (AR) is for PI3-K pathway in the of the anti-androgen which AR, AKT Ser473 phosphorylation. Accordingly, in PC3 cells that AR AKT phosphorylation is to androgens but is AR is in these cells. This non-genomic is supported by an interaction of AR with the PI3-K regulatory subunit p85α as demonstrated by in In that main domains of p85α are in the interaction with AR, the SH3 and the C-terminal SH2 These domains are known to and and AR multiple residues and a in its N-terminal P.W. H.C. C. P. J.A. E. et Steroid Biochem. PubMed Scopus Google Scholar). These data the of this AR in the non-genomic the AR is known to with the SH3 of the kinase and the of an kinase in a in breast and cell lines (16Migliaccio A. Castoria G. Di Domenico M. de Falco A. Bilancio A. Lombardi M. Barone M.V. Ametrano D. Zannini M.S. Abbondanza C. Auricchio F. EMBO J. 2000; 19: 5406-5417Crossref PubMed Google Scholar). we a interaction between AR and p85α in a of can be by the in which domains are and for This interaction between AR and p85α can be with AR in PC3 cells that to an increase in AKT phosphorylation in the of We that AR results in the of known to AR activity in of a in interaction to an increase in AKT phosphorylation level in PC3 cells. is that AR its the to PI3-K these results out that the androgenic activation of PI3-K an alternative pathway by which androgens protect the epithelial cells against apoptosis. are to the of the non-genomic androgen actions We C. White for and of the and D. and for

References

34